Literature DB >> 17850260

Transketolase A, an enzyme in central metabolism, derepresses the marRAB multiple antibiotic resistance operon of Escherichia coli by interaction with MarR.

Francis Domain1, Xiaowen R Bina, Stuart B Levy.   

Abstract

The Escherichia coli marRAB operon specifies two regulatory proteins, MarR (which represses) and MarA (which activates expression of the operon). The latter controls expression of multiple other chromosomal genes implicated in cell physiology, multiple drug resistance and virulence. Using randomly cloned E. coli DNA fragments in the bacterial adenylate cyclase two-hybrid system, we found that transketolase A (TktA) interacts with MarR. Purified (6H)-TktA immobilized on NiNTA resin-bound MarR. Overexpression or deletion of tktA showed that TktA interfered with MarR repression of the marRAB operon. Deletion of tktA increased antibiotic and oxidative stress susceptibilities, while its overexpression decreased them. Hydrogen peroxide induced tktA at 1 h treatment, while an increase in marRAB expression occurred only after 3 h exposure. This increase was dependent on the presence of tktA. Two MarR mutations which eliminated MarR binding to the marRAB operator and one which decreased dimerization of MarR had no effect on MarR interaction with TktA in the two-hybrid system. However, the interaction was disrupted by one of the three tested superrepressor mutant MarR proteins known to increase MarR binding to DNA. TktA inhibition of repression by MarR demonstrates a previously unrecognized level of control of the expression of marRAB operon.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17850260     DOI: 10.1111/j.1365-2958.2007.05928.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  17 in total

1.  Aromatic acid metabolites of Escherichia coli K-12 can induce the marRAB operon.

Authors:  Lon M Chubiz; Christopher V Rao
Journal:  J Bacteriol       Date:  2010-07-16       Impact factor: 3.490

2.  Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance.

Authors:  Cecilia Andrésen; Shah Jalal; Daniel Aili; Yi Wang; Sohidul Islam; Anngelica Jarl; Bo Liedberg; Bengt Wretlind; Lars-Göran Mårtensson; Maria Sunnerhagen
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

Review 3.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 4.  An enzyme in the test tube, and a transcription factor in the cell: Moonlighting proteins and cellular factors that affect their behavior.

Authors:  Constance J Jeffery
Journal:  Protein Sci       Date:  2019-05-24       Impact factor: 6.725

5.  Identification of Avian pathogenic Escherichia coli genes that are induced in vivo during infection in chickens.

Authors:  Huruma Nelwike Tuntufye; Sarah Lebeer; Paul Simon Gwakisa; Bruno Maria Goddeeris
Journal:  Appl Environ Microbiol       Date:  2012-02-17       Impact factor: 4.792

6.  Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli.

Authors:  Cristian Ruiz; Stuart B Levy
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

Review 7.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

8.  Nano-metal oxides induce antimicrobial resistance via radical-mediated mutagenesis.

Authors:  Ye Zhang; April Z Gu; Shanshan Xie; Xiangyang Li; Tianyu Cen; Dan Li; Jianmin Chen
Journal:  Environ Int       Date:  2018-10-25       Impact factor: 9.621

9.  GyrA interacts with MarR to reduce repression of the marRAB operon in Escherichia coli.

Authors:  Francis Domain; Stuart B Levy
Journal:  J Bacteriol       Date:  2009-11-20       Impact factor: 3.490

10.  Effect of MarA-like proteins on antibiotic resistance and virulence in Yersinia pestis.

Authors:  Ida M Lister; Joan Mecsas; Stuart B Levy
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.